执行委员会

Helen V. Ratajczak
PhD

Helen V. Ratajczak has been conducting research on immunology and toxicology since 1967. Her research became focused on autism in 1996 when her three-year-old grandson was diagnosed with the disease. Up to date, Dr. Ratajczak has published more than 80 manuscripts and numerous abstracts for presentations at international and regional conferences. While working for Boehringer Ingelheim Pharmaceuticals, Dr. Ratajczak wrote two drug discovery programs for autism. She was also a Visiting Scientist in 2009-2010 with the Wadsworth Center/NY State Department of Health, where she discussed various aspects of autism. In addition, a proposal by Dr. Rataiczak entitled “Objective Measure of Autism” was authorized by the New England Institutional Review Board in 2011 and is currently funded by Edmond Enterprises, LLC. She is executive committee member of ACMES and peer reviewer of North American Journal of Medicine and Science.

Feng Liu
MD

Feng Liu is clinical assistant professor of Department of Child & Adolescent Psychiatry, NYU Langone Medical Center, New York University School of Medicine, New York. She is also Unit Chief & Attending Psychiatrist, Child Psychiatry Inpatient Unit, and Bellevue Hospital Center. She is executive committee member  of ACMES and To Cure Autism Institute, specialty editor of North American Journal of Medicine and Science.

Gang Wang
MD, PhD

Associate Research Professor, the Brain and Mind Research Institute, Weill Cornell Medical College, Cornell University in New York City. The psychiatric illnesses have different pathophysiological mechanisms, yet these disorders, including autism, major depression, schizophrenia, attention deficit and bipolar disorder, share some genetic aberrations on voltage-gated calcium channels. More and more evidence has shown that CaV1.2 (CACNA1C) not only plays a role in neuroplasticity but also is involved in pathogenesis of autism spectrum disorder. Over the past few years, Dr. Gang Wang has been focusing on the role of voltage-gated Ca2+ channels in psychiatric disorders. He is executive committee member/lecturer of ACMES and editor of North American Journal of Medicine and Science.

William Wilson
MD

Dr. William is a board-certified family doctor at Beverly Hospital. His expertise and interest is the interface between foods and brain function. Dr. William graduated from University of Minnesota Medical School in 1974 and has been practice family medicine for nearly 40 years. He used to practice in Northern Minnesota and has long been interested in research on neuroscience. He has discovered a close relationship between Carbs Syndrome and autism. He is also the physician owner of Wilson Institute of Neurobiology, which is dedicated to understanding the connection between common Psychiatric conditions and common co-morbid medical conditions. He is executive member and lecturer of ACMES and To Cure Autism Institute.

Ming Tong
MD, MBE

Dr. Tong studied Physics and Psychophysics under Nobel laureate Donald Glaser at University of California at Berkeley. He got his double master’s degrees from universities Berkeley and Harvard with double majors in Bioengineering-Neurosciences and Medical Ethics. Prior to completing his MD degree from Boston Medical, he conducted Phase I & Phase II new drug investigations at the federal National Institutes of Health (NIH) Clinical Center. Additional clinical studies and research were acquired from Massachusetts General Hospital and Harvard affiliated teaching hospitals. Ming engaged in basic sciences with collaborative research work of receptor protein complex and cell biology with faculty at Yale, he published abstract in Cell Biology and papers in scientific and medical journals of Experimental Neurology and Investigative Ophthalmology respectively, his discovery of integrin’s receptors morphology in developmental human was posted on the front cover of the journal Investigative Ophthalmology. By the same year he graduated from Medical School, Ming was the first American Chinese recipient of the Award in Research & Education Fund from the National Radiology Society of North America (RSNA) while he was medical student in Boston Medical Center and spent postdoctoral research in Nuclear Medicine. Ming attended 2000+ medical sciences seminars & medical technology conferences, meanwhile serving medical consulting for the global biopharma industry with strong interest in developing new drugs and molecular diagnostic tests for patients worldwide. Ming ‘s personal hobbies ranges from Chinese wok cooking, fusion food and domestic oceanic shark tank automation, a former Marina member of New England Aquarium, volunteer works in the low income minorities community on Early Sciences Education afterschool program. He is executive member  and lecturer of ACMES and To Cure Autism Institute.

Bing Yang
Lis.Ac
Nanci Yuan
MD, DABSM

Dr. Yuan is from San Francisco. She received her BA from the University of California at Berkeley. She received her MD in Philadelphia from Hahnemann University. She trained in pediatrics at Kaiser Oakland. Her fellowship training in pediatric pulmonary and sleep medicine was at Children’s Hospital Los Angeles. Dr. Yuan joined the faculty at Stanford in 2003. In 2005, Dr. Yuan became Medical Director of the Lucile Salter Packard Children's Hospital Pediatric Pulmonary Sleep Laboratory at Stanford University Medical Center. Dr. Yuan is boarded in Pediatric Pulmonary Medicine, Sleep Medicine, and Pediatrics. In the course of her academic career, her medical research has included clinical studies on pulmonary function testing, sleep studies, scoliosis, and neuromuscular disease, of which she has authored several peer-reviewed papers. She is executive member and lecturer of ACMES and To Cure Autism Institute.

Hie-Won Hann
MD

Professor of Medicine at Jefferson Medical College. Dr. Hann has been the director of Liver Disease Prevention Center at Thomas Jefferson University Hospital since 1988. She has also been continuously funded by NIH for carrying out research projects on hepatitis. Since 1996, she has conducted 32 clinical trials and published a total of 280 articles, book chapters and abstracts.  Dr. Hann is also an active speaker in the field of hepatitis B and she has shared her knowledge with healthcare  leaders in the U.S. and Asian countries, including Korea, Philippines, Hong Kong, Singapore, Malaysia, Taiwan, Thailand, China, Vietnam, Australia, Panama and multiple Korean American (and Chinese) churches across the United States.  She also served on CDC Hepatitis B Advisory Group for Asian/Pacific Islander, Immunization Action coalition, Hepatitis B Foundation and National Asian Pacific Leadership Initiative on Cancer. She is executive member  and lecturer of ACMES, peer reviewer of North American Journal of Medicine and Science.

Pages